PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825FHJ23
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $28,406
Award facts
- Contract value 100% obligated
- $28,406.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) Medical Supply Chain valued at $28,406.00 on August 1, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitive award under an existing Indefinite Delivery Contract (IDC) vehicle. The contract is set to complete by August 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, PA. As a child contract under the DLA's larger pharmaceutical procurement framework, this delivery order exemplifies the agency's ongoing procurement of medical supplies and pharmaceuticals through established prime vendor relationships.
AmerisourceBergen Drug Corp operates as a critical supplier within the federal medical procurement ecosystem, holding a significant $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX) through December 2026. The company's extensive federal contracting portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialty medical devices across multiple therapeutic domains. These awards support military healthcare systems, the Defense Health Agency, the U.S. Coast Guard, and other government healthcare organizations. The DLA's Pharmaceutical Prime Vendor Global Program, under which this delivery order falls, is designed to ensure reliable access to critical medical commodities while maintaining competitive procurement practices across multiple therapeutic areas and global regions.
Quick answers
Who was awarded contract SPE2D825FHJ23?
SPE2D825FHJ23 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 1, 2025.
How much is contract SPE2D825FHJ23 worth?
The government has obligated $28,406 on SPE2D825FHJ23.
Is contract SPE2D825FHJ23 an order under another contract?
Yes. SPE2D825FHJ23 is a delivery order under SPE2DX22D0010, an indefinite delivery contract.
Was contract SPE2D825FHJ23 competed?
The extent of competition for SPE2D825FHJ23 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award